Screening of inflammatory bowel disease and spondyloarthritis for referring patients between rheumatology and gastroenterology

Jesús Sanz Sanz1, Xavier Juanola Roura2, Daniel Seoane-Mato3, Miguel Montoro4, Fernando Gomollón5
1Servicio de Reumatología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain
2Servicio de Reumatología, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat (Barcelona), Spain
3Unidad de Investigación, Sociedad Española de Reumatología, Madrid, Spain
4Unidad de Gastroenterología y Hepatología, Hospital General San Jorge, Huesca, Spain
5Unidad de Enfermedad Inflamatoria Intestinal, Servicio de Aparato Digestivo. Hospital Clínico Universitario «Lozano Blesa», Zaragoza, Spain

Tài liệu tham khảo

Karreman, 2016, The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: a systematic review and meta-analysis, J Crohns Colitis, 4, 199, 10.1093/ecco-jcc/jjw199 Conigliaro, 2016, Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients, Autoimmun Rev, 15, 184, 10.1016/j.autrev.2015.11.002 Beslek, 2009, Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease, Rheumatol Int, 29, 955, 10.1007/s00296-008-0811-5 Stolwijk, 2015, Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis, Ann Rheum Dis, 74, 65, 10.1136/annrheumdis-2013-203582 Li, 2013, Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women, Ann Rheum Dis, 72, 1200, 10.1136/annrheumdis-2012-202143 Zohar, 2016, Gastrointestinal comorbidities in patients with psoriatic arthritis, Clin Rheumatol, 35, 2679, 10.1007/s10067-016-3374-y Makredes, 2009, The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis, J Am Acad Dermatol, 61, 405, 10.1016/j.jaad.2009.02.015 Vavricka, 2012, Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease, Inflamm Bowel Dis, 18, 496, 10.1002/ibd.21719 Zaharie, 2016, Diagnostic delay in Romanian patients with inflammatory bowel disease: risk factors and impact on the disease course and need for surgery, J Crohns Colitis, 10, 306, 10.1093/ecco-jcc/jjv215 Sorrentino, 2016, Preclinical and undiagnosed Crohn's disease: the submerged iceberg, Inflamm Bowel Dis, 22, 476, 10.1097/MIB.0000000000000612 Seo, 2015, Delayed diagnosis is linked to worse outcomes and unfavourable treatment responses in patients with axial spondyloarthritis, Clin Rheumatol, 34, 1397, 10.1007/s10067-014-2768-y Robinson, 2014, The window of opportunity: a relevant concept for axial spondyloarthritis, Arthritis Res Ther, 16, 109, 10.1186/ar4561 Claudepierre, 2014, Spondyloarthritis: a window of opportunity?, Joint Bone Spine, 81, 197, 10.1016/j.jbspin.2014.02.008 Battat, 2014, Vitamin B12 deficiency in inflammatory bowel disease: prevalence, risk factors, evaluation, and management, Inflamm Bowel Dis, 20, 1120 Stolwijk, 2013, Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease, Can J Gastroenterol, 27, 199, 10.1155/2013/139702 Alnaqbi, 2013, Development, sensibility, and reliability of the Toronto Axial Spondyloarthritis Questionnaire in inflammatory bowel disease, J Rheumatol, 40, 1726, 10.3899/jrheum.130048 Joven, 2017, Diagnostic value and validity of early spondyloarthritis features: results from the Esperanza Cohort, Arthritis Care Res (Hoboken), 69, 938, 10.1002/acr.23017 Poddubnyy, 2015, Development of an ASAS-endorsed recommendation for the early referral of patients with a suspicion of axial spondyloarthritis, Ann Rheum Dis, 74, 1483, 10.1136/annrheumdis-2014-207151 Stebbings, 2012, Validation of the Dudley Inflammatory Bowel Symptom Questionnaire for the assessment of bowel symptoms in axial SpA: prevalence of clinically relevant bowel symptoms and association with disease activity, Rheumatology (Oxford), 51, 858, 10.1093/rheumatology/ker359 Waugh, 2013, Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation, Health Technol Assess, 17, xv, 10.3310/hta17550 Wendling, 2017, Calprotectin and spondyloarthritis, Expert Rev Clin Immunol, 13, 295, 10.1080/1744666X.2017.1285700 Klingberg, 2017, A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis, Arthritis Res Ther, 19, 21, 10.1186/s13075-017-1223-2 Eubank, 2016, Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathology, BMC Med Res Methodol, 16, 56, 10.1186/s12874-016-0165-8 Lynn, 1986, Determination and quantification of content validity, Nurs Res, 35, 382, 10.1097/00006199-198611000-00017